Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Sennoside D
1. 37271-16-2
2. Uq166p8802
3. (9r)-4-hydroxy-9-[(9r)-4-hydroxy-2-(hydroxymethyl)-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracen-9-yl]-10-oxo-5-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracene-2-carboxylic Acid
4. Sennosid C
5. 26403-11-2
6. Sennoside-c
7. Unii-uq166p8802
8. Chebi:80734
9. Akos025287037
10. Zinc169722601
11. N2676
12. C16797
13. 271s162
14. Q-100439
15. Q27149784
16. Sennoside C (constituent Of Senna Leaf And Pods) [dsc]
17. (9,9'-bianthracene)-2-carboxylic Acid, 5,5'-bis(.beta.-d-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-2'-(hydroxymethyl)-10,10'-dioxo-, (9r,9'r)-rel-
18. (9,9'-bianthracene)-2-carboxylic Acid, 5,5'-bis(beta-d-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-2'-(hydroxymethyl)-10,10'-dioxo-, (r*,r*)-
19. (9r,9'r)-5,5'-bis(beta-d-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-2'-(hydroxymethyl)-10,10'-dioxo-9,9'-bianthracene-2-carboxylic Acid
| Molecular Weight | 848.8 g/mol |
|---|---|
| Molecular Formula | C42H40O19 |
| XLogP3 | 0.8 |
| Hydrogen Bond Donor Count | 12 |
| Hydrogen Bond Acceptor Count | 19 |
| Rotatable Bond Count | 9 |
| Exact Mass | 848.21637904 g/mol |
| Monoisotopic Mass | 848.21637904 g/mol |
| Topological Polar Surface Area | 331 Ų |
| Heavy Atom Count | 61 |
| Formal Charge | 0 |
| Complexity | 1580 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 12 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
24
PharmaCompass offers a list of Sennoside C API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sennoside C manufacturer or Sennoside C supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sennoside C manufacturer or Sennoside C supplier.
PharmaCompass also assists you with knowing the Sennoside C API Price utilized in the formulation of products. Sennoside C API Price is not always fixed or binding as the Sennoside C Price is obtained through a variety of data sources. The Sennoside C Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sennoside C manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sennoside C, including repackagers and relabelers. The FDA regulates Sennoside C manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sennoside C API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sennoside C supplier is an individual or a company that provides Sennoside C active pharmaceutical ingredient (API) or Sennoside C finished formulations upon request. The Sennoside C suppliers may include Sennoside C API manufacturers, exporters, distributors and traders.
Sennoside C Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sennoside C GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sennoside C GMP manufacturer or Sennoside C GMP API supplier for your needs.
A Sennoside C CoA (Certificate of Analysis) is a formal document that attests to Sennoside C's compliance with Sennoside C specifications and serves as a tool for batch-level quality control.
Sennoside C CoA mostly includes findings from lab analyses of a specific batch. For each Sennoside C CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sennoside C may be tested according to a variety of international standards, such as European Pharmacopoeia (Sennoside C EP), Sennoside C JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sennoside C USP).
